Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium therapy in Israel.

J P Hes

    Acta Psychiatrica Scandinavica
    |November 1, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Lithium carbonate treatment for manic-depressive illness began in Israel in 1967. A 1975 survey found 76% of diagnosed patients received this therapy, indicating widespread adoption.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Length of hospitalization and disposition of elderly vs younger delirium patients in psychiatric hospitals.

    The Israel journal of psychiatry and related sciences·1997
    Same author

    Diagnosis of dementia by different specialties.

    The Israel journal of psychiatry and related sciences·1995
    Same author

    Psychiatric hospitalization of dementia patients by commitment order in Israel.

    Medicine and law·1993
    Same author

    [Mental state in old age psychiatry: toward a valid and comprehensive examination].

    Harefuah·1991
    Same author

    Adverse cutaneous reactions to psychotropic drugs.

    Acta dermato-venereologica. Supplementum·1991
    Same author

    Staff attitudes toward violence in the general hospital. A comparison between Amsterdam and Tel Aviv.

    General hospital psychiatry·1990
    Same journal

    Developmental Trauma as a Prognostic Factor for Later Psychotic Disorder in an Adolescent Clinical Cohort: A 20-Year Follow Up Study.

    Acta psychiatrica Scandinavica·2026
    Same journal

    The Prevalence of Obstructive Sleep Apnoea in Schizophrenia, Bipolar Disorder and Major Depressive Disorder: A Systematic Review With Meta-Analysis.

    Acta psychiatrica Scandinavica·2026
    Same journal

    Use of Glucagon-Like Peptide 1 Receptor Agonists and the Associated Risk of Hospitalisation in Bipolar Disorder, From a Nationwide Cohort, 2009-2024.

    Acta psychiatrica Scandinavica·2026
    Same journal

    Benzodiazepine Use and Mortality Risk: A Nationwide Cohort Study on New Benzodiazepine Users With a 5-Year Follow-Up.

    Acta psychiatrica Scandinavica·2026
    Same journal

    Leveraging Family Genetic Risk Scores to Understand the Etiology of Suicidal Behaviors and Their Associations With Psychiatric Disorders.

    Acta psychiatrica Scandinavica·2026
    Same journal

    Does the Loss of Autobiographical Memories Contribute to the Therapeutic Effect of Electroconvulsive Therapy?

    Acta psychiatrica Scandinavica·2026
    See all related articles

    Area of Science:

    • Psychiatry
    • Pharmacology
    • Public Health

    Background:

    • Lithium therapy was introduced for bipolar disorder (manic-depressive illness) in Israel in 1967.
    • Assessing the early adoption and prevalence of lithium treatment is crucial for understanding patient care trends.

    Purpose of the Study:

    • To determine the extent of lithium carbonate treatment among diagnosed manic-depressive patients in Israel.
    • To evaluate the early uptake of lithium therapy following its introduction.

    Main Methods:

    • A questionnaire survey was conducted in 1975.
    • The study population comprised 314 patients diagnosed with manic-depressive illness.
    • Response frequency for the survey was 50%.

    Main Results:

    Related Experiment Videos

    • Out of 314 diagnosed patients, 239 received lithium carbonate treatment.
    • This represents a 76% treatment rate among the surveyed manic-depressive patients.
    • The survey achieved a 50% response rate, providing a significant data subset.

    Conclusions:

    • Lithium carbonate treatment saw substantial uptake among manic-depressive patients in Israel within the first decade of its introduction.
    • The findings highlight the rapid integration of lithium therapy into psychiatric practice for bipolar disorder.